Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons.

Sulzer D, Maidment NT, Rayport S.

J Neurochem. 1993 Feb;60(2):527-35.

PMID:
8419534
3.

Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action.

Fon EA, Pothos EN, Sun BC, Killeen N, Sulzer D, Edwards RH.

Neuron. 1997 Dec;19(6):1271-83.

4.

Weak base model of amphetamine action.

Sulzer D, Pothos E, Sung HM, Maidment NT, Hoebel BG, Rayport S.

Ann N Y Acad Sci. 1992 Jun 28;654:525-8. No abstract available.

PMID:
1632618
5.

Regulation of dopamine quantal size in midbrain and hippocampal neurons.

Pothos EN.

Behav Brain Res. 2002 Mar 10;130(1-2):203-7.

PMID:
11864736
6.

Dopamine neuronal transport kinetics and effects of amphetamine.

Jones SR, Joseph JD, Barak LS, Caron MG, Wightman RM.

J Neurochem. 1999 Dec;73(6):2406-14.

7.

Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport.

Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A.

J Neurosci. 1995 May;15(5 Pt 2):4102-8.

10.
11.

L-3,4-dihydroxyphenylalanine increases the quantal size of exocytotic dopamine release in vitro.

Pothos E, Desmond M, Sulzer D.

J Neurochem. 1996 Feb;66(2):629-36.

PMID:
8592133
13.

Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine.

Vezina P, Lorrain DS, Arnold GM, Austin JD, Suto N.

J Neurosci. 2002 Jun 1;22(11):4654-62.

14.

Reserpine inhibits amphetamine action in ventral midbrain culture.

Sulzer D, St Remy C, Rayport S.

Mol Pharmacol. 1996 Feb;49(2):338-42.

PMID:
8632767
15.
16.

Lobeline inhibits the neurochemical and behavioral effects of amphetamine.

Miller DK, Crooks PA, Teng L, Witkin JM, Munzar P, Goldberg SR, Acri JB, Dwoskin LP.

J Pharmacol Exp Ther. 2001 Mar;296(3):1023-34.

17.

[3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.

Johnson RA, Eshleman AJ, Meyers T, Neve KA, Janowsky A.

Synapse. 1998 Sep;30(1):97-106.

PMID:
9704886
19.

Amphetamine attenuates the stimulated release of dopamine in vivo.

Kuhr WG, Ewing AG, Near JA, Wightman RM.

J Pharmacol Exp Ther. 1985 Feb;232(2):388-94.

PMID:
3968641
Items per page

Supplemental Content

Support Center